SAB Biotherapeutics (SABS) Return on Equity [ROE] (2021 - 2026)
SAB Biotherapeutics (SABS) recorded Return on Equity [ROE] of -30.74% in Q2 2026, up 213.72 percentage points from -244.46% a year earlier but down 1.17 percentage points from the prior quarter.
Powered by 
Analysis
SAB Biotherapeutics (SABS) Return on Equity [ROE] (2021 - 2026) Analysis & Trends
For FY2025, SAB Biotherapeutics reported Return on Equity [ROE] of -53.83%, up 46.91 percentage points from FY2024.
- Annual Return on Equity [ROE] has a four-year change of -9.62 percentage points (FY2021 to FY2025).
- Across earlier years, Return on Equity [ROE] came in at -100.74% in FY2024 (-5.23 pp), -95.51% in FY2023 (-41.66 pp), -53.85% in FY2022 (-9.64 pp) and -44.21% in FY2021.
- Quarterly Return on Equity [ROE] has ranged from -244.46% in Q2 2025 to -29.57% in Q1 2026 over the past five years.
- On a year-over-year basis, Return on Equity [ROE] has increased for four consecutive quarters, with an average year-over-year change of +35.89 percentage points over the last eight quarters.
- Peak year-over-year performance for Return on Equity [ROE] in the last five years was a gain of 213.72 percentage points in Q2 2026, against a drop of 162.96 percentage points in Q2 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at -29.57% (Q1 2026), -30.17% (Q4 2025) and -48.08% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.66% |
| 10 | SAB Biotherapeutics | 279.79 Mn | -130.87 Mn | - | -38.94% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -38.94% |
| Jun 30, 2026 | -6.19% |
| Mar 31, 2026 | -0.27% |
| Dec 31, 2025 | 8.59% |
| Sep 30, 2025 | 21.18% |
| Jun 30, 2025 | -221.64% |
| Mar 31, 2025 | -144.90% |
| Dec 31, 2024 | -109.00% |
| Sep 30, 2024 | -109.65% |
| Jun 30, 2024 | -81.57% |
| Mar 31, 2024 | -72.52% |
| Dec 31, 2023 | -116.24% |
| Sep 30, 2023 | -155.47% |
| Jun 30, 2023 | -132.19% |
| Mar 31, 2023 | -97.56% |
| Dec 31, 2022 | -60.68% |
| Sep 30, 2022 | -66.18% |
| Jun 30, 2022 | -49.51% |
| Mar 31, 2022 | -42.18% |
| Dec 31, 2021 | -44.57% |
API Access
SAB Biotherapeutics Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=SABS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "SABS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=SABS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();